Literature DB >> 15045138

Platelet-endothelial cell interaction in pulmonary micro-circulation: the role of PARS.

Rainer Kiefmann1, Kai Heckel, Sonja Schenkat, Martina Dörger, Józefa Wesierska-Gadek, Alwin E Goetz.   

Abstract

Accumulation of platelets might contribute to acute lung injury during systemic inflammation. The aim of the study was to elucidate the role of the poly (ADP-ribose) synthetase, a nucleotide-polymerizising enzyme, in mediation of platelet-endothelial cell interaction through regulation of adhesion molecules within the pulmonary microcirculation during endotoxemia. We used in vivo fluorescence microscopy to quantify kinetics of fluorescently labeled erythrocytes and platelets in rabbit pulmonary arterioles and venules. Six hours after onset of endotoxin infusion we observed a massive interaction of platelets with the microvascular endothelial cells, whereas under control conditions, no platelet sequestration was measured. An up-regulation of P- and E-selectin was detected in lung tissue following endotoxin infusion by immunohistochemistry and Western blot analysis. Blockade of endothelial P-selectin with fucoidin resulted in a reduction of the endotoxin-induced platelet-endothelial cell interaction. Inhibition of poly (ADP-ribose) synthetase by 3-aminobenzamide inhibited the endotoxin-induced expression of endothelial P- and E-selectin and the subsequent recruitment of platelets. In summary, we provide first in vivo evidence that platelets accumulate in pulmonary microcirculation following endotoxemia. Poly (ADP-ribose) synthetase seems to mediate this platelet-endothelial cell interaction via P- and E-selectin expressed on the surface of microvascular endothelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15045138     DOI: 10.1160/TH03-11-0685

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  16 in total

1.  Preventing ARDS: progress, promise, and pitfalls.

Authors:  Jeremy R Beitler; David A Schoenfeld; B Taylor Thompson
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

Review 2.  Pathophysiology of pulmonary hypertension in acute lung injury.

Authors:  Laura C Price; Danny F McAuley; Philip S Marino; Simon J Finney; Mark J Griffiths; Stephen John Wort
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-13       Impact factor: 5.464

3.  Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study.

Authors:  Jason M Erlich; Daniel S Talmor; Rodrigo Cartin-Ceba; Ognjen Gajic; Daryl J Kor
Journal:  Chest       Date:  2010-08-05       Impact factor: 9.410

4.  Isoflurane prevents acute lung injury through ADP-mediated platelet inhibition.

Authors:  Jeffrey N Harr; Ernest E Moore; John Stringham; Max V Wohlauer; Miguel Fragoso; Wilbert L Jones; Fabia Gamboni; Christopher C Silliman; Anirban Banerjee
Journal:  Surgery       Date:  2012-08       Impact factor: 3.982

5.  Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis.

Authors:  Wei Chen; David R Janz; Julie A Bastarache; Addison K May; Hollis R O'Neal; Gordon R Bernard; Lorraine B Ware
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

6.  The world according to poly(ADP-ribose) polymerase (PARP)--update 2006.

Authors:  Eberhard Barth; Peter Radermacher; Csaba Szabó
Journal:  Intensive Care Med       Date:  2006-08-23       Impact factor: 17.440

7.  Activated platelets in heparinized shed blood: the "second hit" of acute lung injury in trauma/hemorrhagic shock models.

Authors:  Jeffrey N Harr; Ernest E Moore; Max V Wohlauer; Miguel Fragoso; Fabia Gamboni; Xiayuan Liang; Anirban Banerjee; Christopher C Silliman
Journal:  Shock       Date:  2011-12       Impact factor: 3.454

8.  Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients.

Authors:  Jeffrey N Harr; Ernest E Moore; Jeffrey Johnson; Theresa L Chin; Max V Wohlauer; Ronald Maier; Joseph Cuschieri; Jason Sperry; Anirban Banerjee; Christopher C Silliman; Angela Sauaia
Journal:  Crit Care Med       Date:  2013-02       Impact factor: 7.598

Review 9.  Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury.

Authors:  L J Mark Cross; Michael A Matthay
Journal:  Crit Care Clin       Date:  2011-04       Impact factor: 3.598

Review 10.  The role of platelets in acute lung injury (ALI).

Authors:  Alexander Zarbock; Klaus Ley
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.